Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune check-point inhibitors

被引：0
|
作者：
Looman, E. L. [1 ,2 ,3 ]
Cheng, P. F. [1 ,4 ]
Lai-Kwon, J. [5 ]
Morgan, L. [1 ]
Wakkee, M. [3 ]
Dummer, R. [1 ,4 ]
Dimitriou, F. [1 ,4 ]
机构：
[1] Univ Hosp Zurich, Dermatol, Zurich, Switzerland
[2] Univ Hosp Zurich, Radiat Oncol, Zurich, Switzerland
[3] Erasmus MC, Dermatol, Rotterdam, Netherlands
[4] Univ Zurich, Fac Med, Zurich, Switzerland
[5] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
来源：
SWISS MEDICAL WEEKLY | 2023年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
182
引用
收藏
页码：26S / 26S
页数：1
相关论文
共 50 条
  • [41] Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study
    A. Rogiers
    C. Leys
    J. De Cremer
    G. Awada
    A. Schembri
    P. Theuns
    M. De Ridder
    B. Neyns
    Supportive Care in Cancer, 2020, 28 : 3267 - 3278
  • [42] Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study
    Rogiers, A.
    Leys, C.
    De Cremer, J.
    Awada, G.
    Schembri, A.
    Theuns, P.
    De Ridder, M.
    Neyns, B.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (07) : 3267 - 3278
  • [43] Health-related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study
    Grainger, John D.
    Blanchette, Victor S.
    Grotzinger, Kelly M.
    Roy, Anuja
    Bussel, James B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) : 102 - 106
  • [44] Health-Related Quality of Life in Children with Chronic Immune Thrombocytopenia Treated with Eltrombopag in the PETIT Study
    Blanchette, Victor S.
    Grotzinger, Kelly M.
    Marcello, Lisa
    Bakshi, Kalpana
    Brainsky, Andres
    BLOOD, 2012, 120 (21)
  • [45] Health-related quality of life in cancer patients treated with immune checkpoint inhibitors: A systematic review on reporting of methods in randomized controlled trials
    Faury, Stephane
    Foucaud, Jerome
    PLOS ONE, 2020, 15 (01):
  • [46] Mifepristone extends both length and quality of life in a patient with advanced non-small cell lung cancer that progressed despite chemotherapy and check-point inhibitors
    Check, Jerome H.
    Check, Diane
    Poretta, Trina
    CANCER RESEARCH, 2018, 78 (13)
  • [47] Health-related quality of life in intensively treated young patients with type 1 diabetes
    Hanberger, Lena
    Ludvigsson, Johnny
    Nordfeldt, Sam
    PEDIATRIC DIABETES, 2009, 10 (06) : 374 - 381
  • [48] Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies
    Oya, Kazumasa
    Nakamura, Yoshiyuki
    Shen, Larina Tzu-Wei
    Ishizuki, Shoichiro
    Matsusaka, Satoshi
    Fujisawa, Yasuhiro
    JOURNAL OF DERMATOLOGY, 2024, 51 (06): : 807 - 815
  • [49] Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
    Efficace, Fabio
    Vignetti, Marco
    Sparano, Francesco
    Scalzulli, Emilia
    Breccia, Massimo
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (03) : 293 - 302
  • [50] Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors
    Temitope Olufade
    Lisa Gallicchio
    Ryan MacDonald
    Kathy J. Helzlsouer
    Supportive Care in Cancer, 2015, 23 : 447 - 455
12345